| Patents for C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580) |
|---|
| 07/22/2008 | US7402421 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 07/16/2008 | EP1944307A2 Synthetic Salicylihalamides, Apicularens and Derivatives Thereof |
| 07/16/2008 | CN101223153A Dibenzocycloheptane compounds and pharmaceuticals containingthese compounds |
| 07/10/2008 | US20080163790 Dispersants |
| 07/09/2008 | EP1940386A2 Wortmannin conjugates and uses thereof |
| 07/03/2008 | US20080161391 Novel curcumin analogues and uses thereof |
| 07/03/2008 | US20080161287 Bicyclic compound, production and use thereof |
| 06/26/2008 | WO2008075048A2 Polyalkyloxydibenz ( c, e) oxepine derivatives as medicaments |
| 06/26/2008 | US20080153732 mixture contains a lactone, cyclic carbonate and solvents of a glycol ether, for cleaning silicon wafer, an organic electroluminescence material, photosensitive resin, liquid crystal or wax |
| 06/26/2008 | CA2673591A1 Chemical compounds |
| 06/25/2008 | EP1934196A2 Cytotoxin compounds and methods of isolation |
| 06/25/2008 | EP1730140B1 Opioid receptor antagonists |
| 06/25/2008 | CN101205225A Method for preparing lactones by biomimetic catalytic oxidation of ketone compounds |
| 06/24/2008 | US7390831 contraception, secondary amenorrhea; dysfunctional bleeding; uterine leiomyomata; endometriosis; polycystic ovary syndrome; carcinomas, adenocarcinomas, Syndrome X, diabetes; 3'H-spiro-[[1,3]-dioxol-11,12-Dihydroxy-13-methyl-1,6,7,8,11,12,13,14,15,16-decahydro-2H-cyclopenta[a]phenanthrene-3,17-dione |
| 06/24/2008 | US7390803 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; monocyte chemoattractant protein (MCP) receptor antagonist; antiinflammatory agent; antiallergen; autoimmune diseases; rhinitis, dermatitis, asthma |
| 06/19/2008 | WO2008071455A1 Bicyclic acyltryptophanols |
| 06/19/2008 | US20080146821 Internal 1,15-Lactones Of Fluprostenol And Related Prostaglandin F2a Analogs And Their Use In The Treatment Of Glaucoma And Intraocular Hypertension |
| 06/19/2008 | US20080146660 Androgen receptor antagonists; certain cancers such as colon, skin and prostate cancer, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired |
| 06/19/2008 | US20080146654 For therapy of disease of impaired gastric motility |
| 06/18/2008 | CN101203505A Chromane and chromene derivatives and uses thereof |
| 06/12/2008 | US20080139642 Aryl ethers of dihydroartemisnin such as 4-methoxycarbonylmethyl phenyl-dihydroartemisinine ether; immunosuppressants; dosage forms including tablets, ointments and suppositories; side effect reduction over cyclosporin A |
| 06/11/2008 | EP1929313A2 Methods to identify therapeutic agents |
| 06/11/2008 | EP1180107B1 Novel ruthenium metal alkylidene complexes coordinated with triazolylidene ligands that exhibit high olefin metathesis activity |
| 06/05/2008 | US20080132567 Alpha-Aminoamide Derivatives Useful in the Treatment of Lower Urinary Tract Disorders |
| 06/03/2008 | US7381744 inhibit intra-organellar acidification of intracellular organelles; activity in the plasma membranes of kidney intercalated cells, osteoclasts and sperm cells; urinary acidification, bone resorption, or the acrosomal acid secretion required for fertility, adjuncts to cancer therapy |
| 05/28/2008 | CN101186601A Method for catalyzing cyclone oxide to synthesizing lactone by using nano magnesium-base catalyst |
| 05/27/2008 | US7378508 broad spectrum antibiotic activity, in particular, Gram-positive bacteria |
| 05/22/2008 | US20080119543 Method of purifying moxidectin through crystallization |
| 05/21/2008 | EP1923389A1 2-Isopropyl-5-methyloxepan and its use as fragrance compound |
| 05/21/2008 | EP1831191B1 Chroman derivatives and their use as 5-ht receptor ligands |
| 05/21/2008 | CN100389111C Large ring lactone compound containing meta-phenol ring |
| 05/20/2008 | US7375229 Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods |
| 05/20/2008 | US7375099 Malonamide derivatives |
| 05/20/2008 | US7374749 Amino substituted hydroxyphenyl benzophenone derivatives |
| 05/14/2008 | EP1664013B1 Calcilytic compounds |
| 05/13/2008 | US7371772 Bicyclic compound, production and use thereof |
| 05/08/2008 | US20080108838 Novel chiral heptyne derivatives for the preparation of epothilones and processes for their preparation |
| 05/08/2008 | US20080108694 Inhibit the growth of or kill Rb negative cancer cells; inhibit the activity of Heat shock protein 90; antibiotics, antimalarial agents, anticancer agents, antitumor agents; cytotoxicity; to treat glioblastoma, lung cancer and retinoblastoma |
| 05/07/2008 | CN101175741A Intermediate compounds for the prepation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino[4,5-C]pyrrole |
| 05/07/2008 | CN101172972A (S)- or (R)-epsilon-(2-alkyloxyethyl)-epsilon-caprolactone, preparation method and application thereof |
| 05/01/2008 | US20080103234 Dispersants |
| 04/30/2008 | CN100384851C Epothilone derivatives |
| 04/30/2008 | CN100384834C Epothilone derivatives |
| 04/17/2008 | US20080090026 A polymer sustained alignment type of the vertical alignment and optically compensated bend displays having a polymerizable monomer between a transparent substrate and electrode; acrylates of 13,14-Dihydro-12H-dinaphtho[2,1-g;11,2-h][1,5]dioxonine or dinaphthalene ring systems; response; contrast;angle |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN100381566C Recombinant methods and materials for producing epothilone and eopthilone derivatives |
| 04/15/2008 | US7358275 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; The hydrolysis of these analogs releases only the active PGF2 alpha analog free acid, without the production of toxic and irritant small aliphatic alcohol coproducts |
| 04/15/2008 | US7358266 Cyclopropyl and cyclobutyl epothilone analogs |
| 04/10/2008 | WO2008041734A1 Tertiary alkyl ester of oxodibenzoxepin acetic acid |
| 04/10/2008 | US20080085910 For inflammatory bowel disease; oral administration, bioavailability, pharmacokinetics; 2-(2,6-Dichlorobenzamido)-5-[4-(ethyl-pyrimidin-2-ylamino)phenyl]pent-4-enoic acid methyl ester for example |
| 04/09/2008 | EP1908758A1 Process for the preparation of (Z)-[11-(3-dimethylamino-propyliden)-6,11-dihydro-dibenzo[b,e]oxepin-2-yl]-acetic acid hydrochloride |
| 04/09/2008 | CN101160302A Process for the preparation of 9,10-dehydro-12,13-desoxyepothilone derivatives |
| 04/09/2008 | CN101157690A 1-thia-2- hydrocarbon imino-3,4-diaza-9- oxa (aza )-10-oxo spiro [4.15]-3- eicosanic, preparation method and usage as fungicide |
| 04/09/2008 | CN101157678A 12-sulfonyl amido-(15-methyl)-1,15-pentadecanolide, preparation method thereof and application as fungicides |
| 04/08/2008 | US7355081 androgen receptor antagonists; certain cancers, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired |
| 04/08/2008 | US7355042 Sleep disorders; side effect reduction |
| 04/03/2008 | WO2008038877A1 Geldanamycin derivatives by modification of biosynthetic genes |
| 04/03/2008 | US20080081807 Arylphenyl-substituted cyclic keto-enols |
| 03/27/2008 | US20080075718 biodegradable oligomers or polymers used for the controlled, localized and sustained delivery of drugs |
| 03/26/2008 | CN101151256A Process for production of dibenzoxepin derivative |
| 03/26/2008 | CN100376564C Substituted heterocyclic benzoeycloalkenes and the use thereof as substances having analgesic effect |
| 03/25/2008 | US7348417 Method of purifying moxidectin through crystallization |
| 03/20/2008 | US20080070978 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; hydrolysis of these analogs does not have toxic and irritant small aliphatic alcohol coproducts; hypotensive agent for intraocular pressure |
| 02/28/2008 | WO2008023810A1 2-(4-methoxycarbonylmethylphenoxymethyl)benzoic acid methyl ester and method for producing the same |
| 02/27/2008 | EP1891035A1 Substituted benzo-condensed cycloheptanone derivatives and their use for producing drugs |
| 02/21/2008 | WO2008021213A1 Macrocyclic compounds useful as inhibitors of kinases and hsp90 |
| 02/21/2008 | WO2007110761A3 Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof |
| 02/21/2008 | WO2007105234A3 A PROCESS FOR THE PREPARATION OF ISOMERS OF 11-[3-(DIMETHYLAMINO)PROPYLIDENE]-6, 11-DIHYDRODIBENZ [b, e] OXEPIN-2-ACETIC ACID HYDROCHLORIDE AND POLYMORPHS THEREOF |
| 02/21/2008 | CA2696021A1 Macrocyclic compounds useful as inhibitors of kinases and hsp90 |
| 02/20/2008 | EP1889839A1 Bicyclic compound, production and use as HIV inhibitors |
| 02/20/2008 | CN101128436A 甘氨酸衍生物及其用途 Glycine derivatives and their use |
| 02/14/2008 | WO2007119120A3 Crystalline polymorphic forms of olopatadine hydrochloride and processes for their preparation |
| 02/14/2008 | WO2007110704A3 Macrolide compositions as therapeutic agent |
| 02/13/2008 | CN101124212A Chroman derivatives and their use as 5-HT receptor ligands |
| 02/07/2008 | WO2008016105A1 Pharmaceutical composition for prevention and/or treatment of bone disease, functional food or health food comprising the composition, and pharmaceutical preparation comprising the composition as active ingredient |
| 02/06/2008 | CN100366622C 20(S) camptotheca alkaloid derivatives, their preparing methods and uses |
| 02/05/2008 | US7326806 Efficiency |
| 01/30/2008 | EP1881968A2 Dibenzocycloheptane compounds and pharmaceuticals containing these compounds |
| 01/29/2008 | US7323573 Production of polyketides |
| 01/24/2008 | WO2008010776A1 Aigialomycin d and derivatives thereof and their use in treating cancer or malaria or a microbial infection |
| 01/24/2008 | US20080021226 reacting 7,10-dihydroxy-3,7-dimethyl-2-[(1E)-1-methylbuta-1,3-dien-1-yl]-12-oxooxacyclododec-4-en-6-yl acetate and (1R)-1,2-anhydro-dideoxy-1-[(1R,2S)-2-hydroxy-1-methylbutyl]-4-C-vinyl-D-erythro-pentitol in presence of 2-imidazolidinylidene]dichloro(O-isopropoxyphenylmethylene)ruthenium complex |
| 01/24/2008 | US20080020963 11-Methyl-13-Tridecanolide, 12-Methyl-14-Tetradecanolide And 13-Methyl-15-Pentadecanolide, Perfume Compositions Containing The Same, And Process For Production Of Compounds Including The Same |
| 01/23/2008 | CN100363360C Preparation method of e-caprolactone |
| 01/23/2008 | CN100363359C Motilide compounds |
| 01/22/2008 | US7321046 Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof |
| 01/22/2008 | US7320974 Cytoskeletal active compounds, compositions and use |
| 01/10/2008 | US20080008943 Ink composition, inkjet recording method, printed material, method of producing planographic printing plate, and planographic printing plate |
| 01/09/2008 | EP1874756A1 Chromane and chromene derivatives and uses thereof |
| 01/09/2008 | EP1874752A1 Process for the preparation of 9,10-dehydro-12,13-desoxyepothilone derivatives |
| 01/09/2008 | CN100360580C Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds |
| 01/08/2008 | US7317100 C4-demethyl-epothilones or C4-bisnor-epothilones from reacting 2S,6R,7S,9S)-6,7-Epoxy-9-hydroxy-2,6,10-trimethyl-11-(2-methyl-4-thiazolyl)-undec-10-en-1-al with and ethylketone carboxylic acid; macrolactonizing the acid; antitumor, anticancer, antiproliferative |
| 01/08/2008 | US7317026 Sleep disorders; side effect reduction ; antihistamine antagonist |
| 01/03/2008 | US20080004450 cyclization; deprotecting; treatment of cancer and cancer which has developed multidrug-resistant phenotype |
| 12/27/2007 | WO2007148676A1 Therapeutic or prophylactic agent for leukemia |
| 12/27/2007 | WO2007148648A1 Therapeutic or prophylactic agent for multiple sclerosis |
| 12/27/2007 | WO2007110761A8 Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof |
| 12/27/2007 | US20070299252 Erythromycins and Process for Their Preparation |
| 12/27/2007 | CA2655801A1 Therapeutic or prophylactic agent for leukemia |
| 12/27/2007 | CA2655573A1 Therapeutic or prophylactic agent for multiple sclerosis |
| 12/25/2007 | US7312203 1H-8-oxa-1-aza-dibenzo[e,h]azulene; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics |